Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon
Kuai Yu, Rafael Lujan, Alan Marmorstein, Sherif Gabriel, H. Criss Hartzell
Kuai Yu, Rafael Lujan, Alan Marmorstein, Sherif Gabriel, H. Criss Hartzell
View: Text | PDF
Research Article Gastroenterology

Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon

  • Text
  • PDF
Abstract

Anion transport by the colonic mucosa maintains the hydration and pH of the colonic lumen, and its disruption causes a variety of diarrheal diseases. Cholinergic agonists raise cytosolic Ca2+ levels and stimulate anion secretion, but the mechanisms underlying this effect remain unclear. Cholinergic stimulation of anion secretion may occur via activation of Ca2+-activated Cl– channels (CaCCs) or an increase in the Cl– driving force through CFTR after activation of Ca2+-dependent K+ channels. Here we investigated the role of a candidate CaCC protein, bestrophin-2 (Best2), using Best2–/– mice. Cholinergic stimulation of anion current was greatly reduced in Best2–/– mice, consistent with our proposed role for Best2 as a CaCC. However, immunostaining revealed Best2 localized to the basolateral membrane of mucin-secreting colonic goblet cells, not the apical membrane of Cl–-secreting enterocytes. In addition, in the absence of HCO3–, cholinergic-activated current was identical in control and Best2–/– tissue preparations, which suggests that most of the Best2 current was carried by HCO3–. These data delineate an alternative model of cholinergic regulation of colonic anion secretion in which goblet cells play a critical role in HCO3– homeostasis. We therefore propose that Best2 is a HCO3– channel that works in concert with a Cl:HCO3– exchanger in the apical membrane to affect transcellular HCO3– transport. Furthermore, previous models implicating CFTR in cholinergic Cl– secretion may be explained by substantial downregulation of Best2 in Cftr–/– mice.

Authors

Kuai Yu, Rafael Lujan, Alan Marmorstein, Sherif Gabriel, H. Criss Hartzell

×

Figure 4

Isc in WT and Best2–/– distal colonic mucosa.

Options: View larger image (or click on image) Download as PowerPoint
Isc in WT and Best2–/– distal colonic mucosa.
   
Upward currents repres...
Upward currents represent anion movement from serosa to lumen. (A and B) Representative Isc in response to 10 μM forskolin (A) and 1 mM CCh (B) in WT and Best2–/– mice. (C) Peak Isc amplitudes to forskolin or CCh in WT and Best2–/– mice (n = 6–10). *P < 0.05 versus WT, Student’s t test. (D–I) Isc mediated by Cl– and HCO3–. Solutions contained 5 mM Ba2+ and 0.1 mM amiloride. (D) Effect of HCO3– removal on CCh-stimulated current in WT mucosa. In normal Krebs solution, CCh induced a rapid peak followed by plateau. HCO3– removal inhibited the plateau. (E) Average Isc in WT and Best2–/– mice. CCh was added at 2 minutes. (F and G) CCh-stimulated current in WT (F) and Best2–/– (G) mucosa in normal Krebs and HCO3–-free solutions. (H) Replot of data in F and G comparing Cl– currents in HCO3–-free Krebs in WT and Best2–/– mice. (I) Comparison of Cl– and HCO3– currents stimulated by CCh in WT and Best2–/– mucosa. Total, current in normal Krebs; Cl, Cl– current in HCO3–-free solution; HCO3(P), amplitude of plateau current 8 minutes after CCh application in normal Krebs; HCO3(D), difference between currents at peak (about 1–2 minutes after CCh application) in normal Krebs and in HCO3–-free solution. n = 10 per data point.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts